Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
Felice Gragnano, Associate Professor and Cardiologist at Università Vanvitelli, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
“Thrilled to share our latest review article published in Journal of Clinical Medicine (JCM) MDPI
‘Antiplatelet Modulation Strategies After PCI in Patients Without an Indication for Oral Anticoagulation’.
As ischemic and bleeding risks evolve over time after PCI, antiplatelet therapy should evolve with them. In this comprehensive review, we explore:
- Antiplatelet de-escalation strategies
- P2Y12 inhibitor monotherapy
- Guided and unguided switching strategies
- Antiplatelet escalation in patients at increased ischemic risk
- Latest RCTs and implications for clinical practice.
The key message: moving toward dynamic, risk-adapted, and personalized antiplatelet therapy.
A sincere thank you to all colleagues and international experts who contributed to this collaborative work, and special thanks to Prof. Paolo Calabrò for his leadership, guidance, and continued support.”
Title: Antiplatelet Modulation Strategies After PCI in Patients Without an Indication for Oral Anticoagulation
Authors: Felice Gragnano, Vincenzo De Sio, Antonio Capolongo, Giuseppe Verde, Giovanni Pio Iannotti, Angelo Romano, Elio Mattia Migliaccio, Michelangelo Luciani, Gabriele Cappiello, Elisabetta Moscarella, Simona Sperlongano, Vincenzo Acerbo, Arturo Cesaro, Dobromir Dobrev, Antonio Landi, Diana A. Gorog, Dominick J. Angiolillo, Marco Valgimigli, Paolo Calabrò

Stay updated with Hemostasis Today.
-
Nov 19, 2026, 13:11When Postpartum Warning Signs Are Ignored – National Blood Clot Alliance
-
Nov 19, 2026, 12:56Batool Abuhalimeh: The Hidden Psychological Burden of Pulmonary Embolism
-
Nov 19, 2026, 12:45Pedro Perez: PE Recovery – From Acute Treatment to Long-Term Follow-Up
-
Nov 19, 2026, 12:34Edward Lee Carter: Are We Ready for FXIa Inhibitors?
-
Nov 19, 2026, 12:19Essama Telli: When a Bruise Doesn’t Heal – Recognising the Warning Signs
-
Nov 19, 2026, 11:51Wolfgang Miesbach: Beyond Episomal Gene Therapy in Haemophilia B
-
Nov 19, 2026, 11:18A First Look at WFH CCS 2027
-
Nov 19, 2026, 10:58Does a Higher Measured Factor Level Always Mean Better Protection Against Joint Bleeds? – Global Hemophilia Report
-
Nov 19, 2026, 10:43Strengthening Plasma Management and Patient Access Across Eastern Europe – ISBT